+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
NeoGenomics Laboratories Inc - logo

NeoGenomics Laboratories, Inc. provides cancer diagnostics and pharma services to oncologists, pathologists, pharmaceutical companies, academic centers, and others. It offers hematopathology, solid tumor, tumor profile, liquid biopsy, hereditary cancer, and women's health testing services through cytogenetic, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry and in situ hybridization, and molecular methodologies. The company was founded in 2001 and is based in Fort Myers, Florida. It has locations in Nashville, Tennessee; Houston, Texas; and Irvine, Fresno, and Aliso Viejo, California.

Global Liquid Biopsy Market - Outlook & Forecast 2023-2028 - Product Thumbnail Image

Global Liquid Biopsy Market - Outlook & Forecast 2023-2028

  • Report
  • October 2023
  • 377 Pages
  • Global
From
Cancer Tumor Profiling Market Report 2026 - Product Thumbnail Image

Cancer Tumor Profiling Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Liquid Biopsy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liquid Biopsy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
From
Minimal Residual Disease Testing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Minimal Residual Disease Testing Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
From
From
Cancer/Tumor Profiling Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer/Tumor Profiling Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
From
From
The Worldwide Market for Liquid Biopsy, 6th Edition - Product Thumbnail Image

The Worldwide Market for Liquid Biopsy, 6th Edition

  • Report
  • December 2023
  • 220 Pages
  • Global
From
From
Loading Indicator